Abound Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85K | Buy |
13
+5
| +63% | +$1.09K | ﹤0.01% | 692 |
|
|
2025
Q1 | $1.79K | Sell |
8
-4
| -33% | -$896 | ﹤0.01% | 714 |
|
|
2024
Q4 | $3.93K | Buy |
12
+3
| +33% | +$983 | ﹤0.01% | 576 |
|
|
2024
Q3 | $2.7K | Hold |
9
| – | – | ﹤0.01% | 666 |
|
|
2024
Q2 | $2.97K | Sell |
9
-10
| -53% | -$3.3K | ﹤0.01% | 596 |
|
|
2024
Q1 | $7.52K | Buy |
19
+7
| +58% | +$2.77K | ﹤0.01% | 433 |
|
|
2023
Q4 | $4.23K | Hold |
12
| – | – | ﹤0.01% | 550 |
|
|
2023
Q3 | $4.51K | Sell |
12
-1
| -8% | -$375 | ﹤0.01% | 489 |
|
|
2023
Q2 | $4.97K | Buy |
13
+2
| +18% | +$765 | ﹤0.01% | 484 |
|
|
2023
Q1 | $3.81K | Hold |
11
| – | – | ﹤0.01% | 473 |
|
|
2022
Q4 | $2.59K | Buy |
11
+8
| +267% | +$1.88K | ﹤0.01% | 497 |
|
|
2022
Q3 | $739 | Buy |
+3
| New | +$739 | ﹤0.01% | 632 |
|